Table 1.
Methods | |||
---|---|---|---|
Components | Indication | Interventions | Adoptions to special settings and situations |
Aerobic exercise: Endurance Training (limited evidence on COVID)1, 8, 9, 31, 78, 81, 82, 88 |
- Impaired exercise capacity, limited by dyspnoea, fatigue and or other symptoms. - Restriction in daily life activities. |
• Treadmill and/or cycle-ergometer • 30 min. 2–5 times/week for 4–8 weeks • Continuous or interval training • Low-Intensity (40–60%) or Hight-Intensity (60–80%) set according to - maximal heart rate (220-age) or - maximal oxygen consumption or - the equation of Luxton or - symptom limited (target Borg scale ≤4) • In- or out-patients or tele-monitoring • Suggest maintenance program |
• Free walks 30 min. 2–5 times/week for 4–8 weeks • Intensity set according to perceived symptoms (target Borg scale ≤4) • Out-patients or home setting • Suggest maintenance program |
Strength training: Upper and lower extremities (limited evidence on TB and COVID)1, 9, 31, 78, 81, 82, 88 |
Sarcopenia, reduced strength of peripheral muscles. Lower muscle weakness with risk for falls. Impaired activities of daily living involving the upper extremities (including dressing, bathing, and household tasks) | • free weights (dumbbells and ankle-brace) • 20–30 min. 2–5 times/week for 4–8 weeks • 2–3 set of 6–12 repetitions • Intensity set to 80% of MVV or 1MR and/or adjusted on perceived muscles fatigue (target Borg scale ≤4) • In or out-patients or tele-monitoring Suggest maintenance program |
• free weights (dumbbells and ankle-brace) • 20–30 min. 2–5 times/week for 4–8 weeks 2–3 set of 6–12 repetitions • Intensity set according to perceived muscles fatigue (target Borg scale ≤4) • Out-patients or home setting • Suggest maintenance program |
Inspiratory muscle training (limited evidence on TB and COVID)1, 79, 96 | Impaired respiratory muscle function, altered respiratory mechanics, decreased chest wall compliance or pulmonary hyperinflation | • load threshold devices, seated and using a nose clip • Intensity/load set at 30–60% of maximal inspiratory pressure • Interval training, 3 sets with10 breaths followed by 1-minute break between each set. • 15–20 min. 2–5 times/week for 4–8 weeks |
Not applicable |
Calisthenics and stretching exercises (limited evidence on TB and COVID)31, 79, 82 | Impaired daily life activities | • Calisthenics exercises • Stretching exercises • Nordic walking or Aqua fitness or home exercise • 2–5 times per week for 30 min |
• Calisthenics exercises • Stretching exercises • Home exercises • 2–5 times per week for 30 min |
Respiratory exercise (limited evidence on TB and COVID)31, 78, 79, 82 | Dynamic hyperinflation Resting tachypnea Dyspnoea |
• Adaptive breathing strategies • yoga breathing • pursed-lips breathing • computer-aided • breathing feedback • 2–4 times per week for 30 min each |
• Adaptive breathing strategies • yoga breathing • pursed-lips breathing • computer-aided • 2–4 times per week for 30 min each |
Education (limited evidence on TB and COVID)31, 78 | Impaired/reduced self-efficacy and collaborative Self-Management | • Structured and comprehensive educational programmes • Age specific, gender-sensitive, delivered in the local language and extended to family and/or care-givers • Individual or group sessions • 15–60 min. • Importance of physical activity and exercise to improve quality of life • Maintaining results achieved with pulmonary rehabilitation (follow-up plan) • Advantages/importance of smoking cessation and risk of comorbidities (e.g., diabetes, etc.) • Importance of adhering to medical prescriptions in terms of management of comorbidities and vaccinations • Achieving an optimal healthy life style |
• Structured and comprehensive educational programmes • Age specific, gender-sensitive, delivered in the local language and extended to family and/or care-givers • Individual or group sessions • 15–60 min. • Importance of physical activity and exercise to improve quality of life • Maintaining results achieved with pulmonary rehabilitation (follow-up plan) • Advantages/importance of smoking cessation and risk of comorbidities (e.g., diabetes, etc.) • Importance of adhering to medical prescriptions in terms of management of comorbidities and vaccinations • Achieving an optimal healthy life style |
Psychological support (limited evidence on COVID)1, 31, 78, 80, 81, 105, 105 | Depression, anxiety and cognitive dysfunction | • Psychological assessment • Psychological support • Relaxation technique • Consider self-help group |
• Psychological assessment • Psychological support • Relaxation technique • Consider Self-help group |
Airway clearance techniques (limited evidence on COVID)1, 31, 78, 97 | Difficult to remove secretions or mucous plugs. Frequent bronchial exacerbations (≥2/year). Concomitant diagnosis of bronchiectasis. |
• Choose the technique suitable for the subject among those available, based on respiratory capacity, mucus rheology, collaboration and patient preferences • 15–30 minutes one or more times/day • Choose the duration of treatment based on chronic (long term) or acute problem (short term) • Suggest maintenance program when needed |
• Choose the technique suitable for the subject among those available, based on respiratory capacity, mucus rheology, collaboration and patient preferences • 15–30 minutes one or more times/day choose the duration of treatment based on chronic (long term) or acute problem (short term) • Suggest maintenance program when needed |
Long term oxygen therapy (limited evidence on TB and COVID)1, 78, 98, 99 | Resting hypoxemia despite stable condition and optimal medical therapy (partial pressure of oxygen < 7.3 kPa (<55 mmHg) or ≤8 kPa (≤60 mmHg) with evidence of peripheral oedema, polycythaemia (haematocrit ≥55%) or pulmonary hypertension). | Titrate oxygen flow that maintain oxygen saturation >92–93%. • Long term oxygen therapy should be initiated on a flow rate of 1 L/min and titrated up in 1 L/min increments until oxygen saturation >90%. An arterial blood gas analysis should then be performed to confirm that a target partial pressure of oxygen ≥8 kPa (60 mm Hg) at rest has been achieved. • Ambulatory and nocturnal oximetry may be performed to allow more accurate flow rates to be ordered for exercise and sleep, respectively during rest, sleep and exertion. • Provide formal education to patients referred to home • Schedule periodic re-assessment at 3 months |
Titrate oxygen flow that maintain oxygen saturation > 92–93%. • Long term oxygen therapy should be initiated on a flow rate of 1 L/min and titrated up in 1 L/min increments until oxygen saturation > 90% at rest has been achieved. • Non-hypercapnic patients initiated on long term oxygen therapy should increase their flow rate by 1 L/min during sleep in the absence of any contraindications. • Ambulatory oximetry may be performed to allow more accurate flow rates to be ordered for exercise • Provide formal education to patients referred to home • Schedule periodic re-assessment at 3 months |
Long-term nocturnal non invasive mechanical ventilation (limited evidence on TB and COVID)1, 77, 100 | Chronic stable hypercapnia (partial pressure of carbon dioxide >6–8 kPa (45–60 mmHg)), despite optimal medical therapy. non-invasive ventilation could be applied during aerobic training in case of severe breathlessness or reduced exercise resistance. |
• Not initiating long-term non-invasive ventilation during an admission for acute on-chronic hypercapnic respiratory failure, favoring reassessment at 2–4 weeks after resolution • Titrate non-invasive ventilation setting • Titrate mask • Plan education • Consider non-invasive ventilation during exercise • Schedule an educational meeting and verifies the ability of the subject and/or a caregiver to manage the non-invasive ventilation at home |
• Probably not applicable |
Nutritional support (limited evidence on COVID)1, 78, 101, 102, 103 | Body composition abnormalities | • Nutritional assessment • Tailored treatment from foods and medical supplements |
• Nutritional assessment • Tailored treatment from foods and medical supplements • Need for financial incentives and transportation access should be evaluated |